PlainRecalls
FDA Drug Low Class III Ongoing

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Reported: November 15, 2023 Initiated: October 17, 2023 #D-0088-2024

Product Description

Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11

Reason for Recall

Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.

Details

Recalling Firm
AbbVie Inc.
Units Affected
864 cartons
Distribution
Distributed in the US. No government or foreign consignees.
Location
North Chicago, IL

Frequently Asked Questions

What product was recalled?
Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chicago, IL 60064, U.S.A. NDC 0074-7068-11. Recalled by AbbVie Inc.. Units affected: 864 cartons.
Why was this product recalled?
Labeling: Wrong Barcode- One (1) of every forty (40) unit dose blister will contain incorrect barcode information that causes a 125mcg unit dose is scanned as 200mcg unit dose.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 15, 2023. Severity: Low. Recall number: D-0088-2024.